We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.02B
1-Year Est. Return 53.92%
This Fund
S&P 500
This Quarter Est. Return
+40.54%
1 Year Est. Return
+53.92%
3 Year Est. Return
+208.37%
5 Year Est. Return
+342.22%
10 Year Est. Return
+3,246.09%
AUM
$2.3B
AUM Growth
+$611M
Cap. Flow
+$70.8M
Cap. Flow %
3.08%
Top 10 Hldgs %
28.53%
Holding
404
New
68
Increased
97
Reduced
78
Closed
70

Sector Composition

Rank Sector Weight
1 Technology 31.5%
2 Healthcare 15.29%
3 Consumer Discretionary 14.62%
4 Financials 10.78%
5 Industrials 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MODN
101
DELISTED
MODEL N, INC.
MODN
$6.83M 0.3%
196,486
-16,375
-8% -$477K
PLNT icon
102
Planet Fitness
PLNT
$4.45B
$6.67M 0.29%
110,180
+106,210
+2,675% +$6.38M
BHVN
103
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$6.61M 0.29%
+90,450
New +$4.81M
RARE icon
104
Ultragenyx Pharmaceutical
RARE
$2.46B
$6.52M 0.28%
83,350
-850
-1% -$56.3K
DY icon
105
Dycom Industries
DY
$11.2B
$6.08M 0.26%
+148,600
New +$5.13M
SHYF
106
DELISTED
The Shyft Group
SHYF
$6.07M 0.26%
360,510
+39,375
+12% +$595K
MNTA
107
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$5.95M 0.26%
+178,755
New +$5.69M
CVX icon
108
Chevron
CVX
$382B
$5.91M 0.26%
66,195
+61,260
+1,241% +$5.48M
WSC icon
109
WillScot Mobile Mini Holdings
WSC
$4.37B
$5.89M 0.26%
+479,530
New +$5.91M
WEN icon
110
Wendy's
WEN
$1.46B
$5.88M 0.26%
270,184
-138,115
-34% -$2.75M
META icon
111
Meta Platforms (Facebook)
META
$1.49T
$5.87M 0.26%
25,860
-151,420
-85% -$31.6M
LVGO
112
DELISTED
Livongo Health, Inc. Common Stock
LVGO
$5.84M 0.25%
+77,718
New +$4.07M
INSM icon
113
Insmed
INSM
$22.4B
$5.58M 0.24%
+202,575
New +$4.8M
OLED icon
114
Universal Display
OLED
$3.75B
$5.57M 0.24%
37,240
+34,560
+1,290% +$5.07M
CSTL icon
115
Castle Biosciences
CSTL
$742M
$5.57M 0.24%
+147,725
New +$5.05M
IIIV icon
116
i3 Verticals
IIIV
$419M
$5.56M 0.24%
+183,814
New +$4.67M
TSEM icon
117
Tower Semiconductor
TSEM
$21.2B
$5.32M 0.23%
278,815
-775
-0.3% -$14.8K
MRTX
118
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$5.32M 0.23%
46,560
-520
-1% -$50.4K
AUDC icon
119
AudioCodes
AUDC
$239M
$5.28M 0.23%
+166,160
New +$5.11M
CHGG icon
120
Chegg
CHGG
$116M
$5.27M 0.23%
+78,415
New +$4.19M
QDEL icon
121
QuidelOrtho
QDEL
$1.13B
$5.21M 0.23%
+23,305
New +$3.65M
NSP icon
122
Insperity
NSP
$2.03B
$5.14M 0.22%
+79,435
New +$3.98M
STMP
123
DELISTED
Stamps.com, Inc.
STMP
$5.03M 0.22%
+27,395
New +$4.69M
ITRI icon
124
Itron
ITRI
$4.54B
$4.89M 0.21%
+73,760
New +$4.7M
COP icon
125
ConocoPhillips
COP
$144B
$4.79M 0.21%
114,015
+108,555
+1,988% +$4.39M

Similar funds

Castleark Management's Q2 2020 Portfolio in Review

As of Q2 2020, Castleark Management held 404 positions worth $2.3B, up 36% from $1.69B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Castleark Management deployed $70.8M of net new capital in Q2 2020, opening 68 new positions and adding to 97 existing holdings. Its largest new stake was State Street Financial Select Sector SPDR ETF: 1,747,900 shares worth $40.4M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 35% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $31.6M trimmed.

  • Castleark Management's largest Q2 2020 buy was State Street Financial Select Sector SPDR ETF: 1,747,900 shares worth $40.4M.
  • Castleark Management added most to Home Depot in Q2 2020, an estimated $29.8M increase.
  • Castleark Management's biggest Q2 2020 reduction was Meta Platforms (Facebook), cutting an estimated $31.6M.
  • Castleark Management fully exited Alibaba in Q2 2020, selling an estimated $31.3M.
  • Castleark Management's ten largest holdings make up 29% of its $2.3B portfolio in Q2 2020.
  • Castleark Management opened 68 new positions and closed 70 in Q2 2020.
  • Castleark Management's portfolio value rose 36% quarter-over-quarter to $2.3B.

Based on Castleark Management's 13F filing for Q2 2020, filed 14 Aug 2020.